Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruben J M Mijnster

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Lancet (London, England)|June 11, 2026
Challenges in assessing statin-associated adverse eventsMarte F van der Bijl, Ruben J M Mijnster, P Hugo M van der Kuy, et al.
Current Atherosclerosis Reports|January 28, 2025
Lipid Lowering Therapy Utilization and Lipid Goal Attainment in WomenJulie A E van Oortmerssen, Janneke W C M Mulder, Marte F van der Bijl, et al.
Atherosclerosis|June 1, 2025
Efficacy and safety of PCSK9 monoclonal antibodies in older patients: A real-world registryRuben J M Mijnster, Janneke W C M Mulder, Annette M H Galema-Boers, et al.
Atherosclerosis|September 23, 2025
Patient perspectives on statin intolerance, attribution of the nocebo effect and use of N=1-interventions: a qualitative focus group studyRuben J M Mijnster, Marte F van der Bijl, Amber Niesthoven, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Lancet (London, England)|June 11, 2026
Challenges in assessing statin-associated adverse eventsMarte F van der Bijl, Ruben J M Mijnster, P Hugo M van der Kuy, et al.
Current Atherosclerosis Reports|January 28, 2025
Lipid Lowering Therapy Utilization and Lipid Goal Attainment in WomenJulie A E van Oortmerssen, Janneke W C M Mulder, Marte F van der Bijl, et al.
Atherosclerosis|June 1, 2025
Efficacy and safety of PCSK9 monoclonal antibodies in older patients: A real-world registryRuben J M Mijnster, Janneke W C M Mulder, Annette M H Galema-Boers, et al.
Atherosclerosis|September 23, 2025
Patient perspectives on statin intolerance, attribution of the nocebo effect and use of N=1-interventions: a qualitative focus group studyRuben J M Mijnster, Marte F van der Bijl, Amber Niesthoven, et al.
Pageof 1